Clover Assistant also utilizes machine learning to synthesize that data with member-specific information. The platform provides doctors with actionable and personalized insights at the point of care and offers suggestions for medications and dosages, tests, or referrals. Ultimately, helping patients improve their health and well-being.
As a technology innovator, Clover believes its software is the core of its business in the Medicare Advantage space.
Clover Co-Founder and CEO Vivek Garipalli claimed that the company “pioneered a fundamentally different approach to Medicare Advantage that focuses on driving affordability and partnering closely with physicians to deliver the best possible health outcomes for members.”
Chamath Palihapitiya believes Clover can disrupt the Medicare Advantage market
Following the merger, SCH will be immediately renamed Clover Health Investments, Corp. Its goal is to jumpstart Clover’s already impressive growth trajectory.
Chamath Palihapitiya formed SCH to unite “technologists, entrepreneurs, and technology-oriented investors around a shared vision of identifying and investing in innovative and agile technology companies.”
